Key result
Regular aspirin use surged across three decades, rising to ~74% for secondary CVD prevention.
Cross-Sectional (n=26,539)
No
Regular aspirin use for both primary and secondary cardiovascular disease prevention increased substantially among urban US adults between 1980 and 2009 without an accompanying rise in population-level hospitalizations for gastrointestinal bleeding or hemorrhagic stroke, though potential underuse in high-risk patients and inappropriate use in low-risk young adults remain concerns.
Answers are grounded in this paper and cite their sources.
Observed increases in aspirin use warrant caution against overuse in low-risk groups; leaves open the need for updated risk-benefit assessments in modern cohorts.
BACKGROUND: Daily low-dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher-risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/St. Paul, 2010 population 2.85 million) from 1980 to 2009 were evaluated. METHODS AND RESULTS: Surveys of randomly selected adults aged 25 to 74 years were collected at 5-year intervals. Self-reports of regular aspirin use for CVD prevention and history of CVD were obtained. Six cross-sectional surveys included 12 281 men and 14 258 women. Age-adjusted aspirin use for primary prevention increased during this period from 1% to 21% among men and 1% to 12% among women. Aspirin use was highest in those aged 65 to 74 years. For secondary prevention, age-adjusted aspirin use increased from 19% to 74% among men and 11% to 64% among women. While data are based on self-report, a substudy using a biochemical indicator of aspirin use (serum thromboxane B2) supports the validity of self-report. CONCLUSIONS: Aspirin for CVD prevention is commonly used by a large and growing portion of the general population. It is not known if this is based on professional advice or self-prescribed use. It is also likely that many who would benefit do not use aspirin and others use aspirin inappropriately.
No takes yet. Share an insight, caveat, or question.
Luepker et al. (2015) conducted a cross-sectional in Cardiovascular disease prevention (primary and secondary) (n=26,539). Regular aspirin use for cardiovascular disease prevention was evaluated on Age-adjusted prevalence and temporal trends in self-reported regular aspirin use for primary and secondary cardiovascular disease prevention (p=<0.0001). Regular aspirin use from 1980 to 2009 increased from 1% to 21% in men and 1% to 12% in women for primary prevention, and from 19% to 74% in men and 11% to 64% in women for secondary prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: